FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / News / Read News


BofA Merrill Lynch Leads $550MM Financing for Amedisys

July 02, 2018, 07:09 AM
Filed Under: Healthcare

Amedisys, Inc.,an independent home health, hospice care and personal care company, announced that it entered into a new secured revolving credit facility on June 29, 2018. The new credit facility expands the Company's borrowing capacity by $250 million to $550 million.  The new facility also has an expansion option to allow for further upsizing should the Company require additional capital. The initial pricing will result in an interest rate reduction at current leverage levels of 50 basis points compared to the current credit facility.

Amedisys used proceeds from the facility to pay off its existing senior term loan and revolving credit line balance. The Company plans to utilize additional proceeds from this upsized facility to capitalize on a strong pipeline of acquisition opportunities. The lender group was composed of ten banks, led by Bank of America Merrill Lynch, as Administrative Agent and Joint Bookrunner, JPMorgan Chase Bank, N.A., as Co-Syndication Agent and Joint Bookrunner and Fifth Third Bank and Citizens Bank, N.A., as Joint Lead Arrangers.

Paul B. Kusserow, President and Chief Executive Officer, stated, "We are excited about the expansion of our credit facility that capitalizes on our strong balance sheet and cash flow profile.  The new facility will provide us with increased operational flexibility, reduced pricing and incremental capital for acquisition opportunities in our pipeline. As always, we appreciate the support of our lender group, the majority of whom have been lenders for several years, who helped to facilitate the execution of this refinancing."

Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.